ストックスクリーナーアプリを入手
1.63
5.16%
0.08
前日終値:
$1.55
開ける：
$1.55
24時間の取引高:
41,655
Relative Volume:
0.65
時価総額：
$59.67M
収益：
$134.00K
当期純損益:
$-9.93M
株価収益率:
-4.4054
EPS:
-0.37
ネットキャッシュフロー:
$-6.72M
1週間 パフォーマンス:
-8.43%
1か月 パフォーマンス:
-11.89%
6か月 パフォーマンス:
-31.80%
1年 パフォーマンス:
+123.29%
1日の値動き範囲:
$1.5373
$1.69
1週間の範囲:
$1.5373
$1.79
52週間の値動き範囲:
$0.52
$3.35
Entera Bio Ltd Stock (ENTX) Company Profile
名前
Entera Bio Ltd
セクター
電話
972-2-532-7151
住所
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
ENTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| ENTX | 1.63 | 59.67M | 134.00K | -9.93M | -6.72M | -0.37 |
| VRTX | 449.73 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.37 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 599.51 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.03 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-22 | 開始されました | Aegis Capital | Buy |
Entera Bio Ltd (ENTX) 最新ニュース
Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com
Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat
FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat
HC Wainwright Reaffirms Buy Rating for Entera Bio (NASDAQ:ENTX) - MarketBeat
Entera Bio Ltd. (ENTX) Quarterly 10-Q Report - Quartzy
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Entera Bio Highlights Q3 2024 Financials and FDA Anticipation - TipRanks
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates - The Manila Times
Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Drops By 14.4% - MarketBeat
Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in September - MarketBeat
Entera Bio outlook steady as H.C. Wainwright backs potential of total hip BMD in osteoporosis care - Investing.com Australia
Entera Bio (NASDAQ:ENTX) Rating Reiterated by HC Wainwright - MarketBeat
Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - MSN
Entera Bio shares hold Buy rating on OXM study success By Investing.com - Investing.com Australia
Entera Bio shares hold Buy rating on OXM study success - Investing.com
Entera Bio's (ENTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Entera Bio and OPKO Health report promising obesity treatment study By Investing.com - Investing.com Australia
Entera Bio and OPKO Health report promising obesity treatment study - Investing.com
Entera Bio And Opko Health Provide Update On Pk/Pd Results Of Oral Oxyntomodulin (Glp-1/Glucagon) Peptide Tablet Candidate For Obesity And Metabolic Disorders - XM
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide - EIN News
Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? - MSN
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? - MSN
Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Yahoo Finance
Entera Bio to Participate in Upcoming Investor and Scientific Conferences - GlobeNewswire
All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy - Yahoo Finance
Entera Bio Ltd. Forecasted to Earn Q3 2024 Earnings of ($0.05) Per Share (NASDAQ:ENTX) - Defense World
Entera Bio Ltd. to Post Q3 2024 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:ENTX) - MarketBeat
Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 51.0% in July - MarketBeat
Entera Bio (NASDAQ:ENTX) Releases Earnings Results - MarketBeat
Entera Bio's (ENTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
HC Wainwright Reiterates Buy Rating for Entera Bio (NASDAQ:ENTX) - Defense World
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates - GlobeNewswire
Virtu Financial LLC Invests $37,000 in Entera Bio Ltd. (NASDAQ:ENTX) - Defense World
Entera Bio Ltd expected to post a loss of 6 cents a shareEarnings Preview - XM
The 10 Best Biotech Stocks Under $5 To Buy For September 2024! - The Stock Dork
Entera Bio shareholders approve executive compensation, board appointments - Investing.com
Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual MeetingKey SABRE Update Also Expected - StockTitan
Entera Bio (NASDAQ:ENTX) Trading Up 1.9% - MarketBeat
Entera Bio (NASDAQ:ENTX) Stock Price Up 1.9% - Defense World
Entera Bio (NASDAQ:ENTX) & Vericel (NASDAQ:VCEL) Financial Survey - Defense World
Short bowel syndrome Market Positive Outlook: Phase Bio , Orphan Technologies , Zealand Pharma - Newstrail
3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years - Markets Insider
Entera Bio Ltd (ENTX) 財務データ
収益
当期純利益
現金流量
EPS
Entera Bio Ltd (ENTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Taitel Haya | Director |
Jan 10 '24 |
Buy |
0.77 |
7,615 |
5,864 |
25,615 |
| LIEBERMAN GERALD M | Director |
Dec 22 '23 |
Buy |
0.71 |
23,952 |
17,006 |
226,961 |
| Toledano Miranda Jayne | Chief Executive Officer |
Dec 22 '23 |
Buy |
0.71 |
23,952 |
17,006 |
110,752 |
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):